553 related articles for article (PubMed ID: 20890287)
21. PAWS1 controls Wnt signalling through association with casein kinase 1α.
Bozatzi P; Dingwell KS; Wu KZ; Cooper F; Cummins TD; Hutchinson LD; Vogt J; Wood NT; Macartney TJ; Varghese J; Gourlay R; Campbell DG; Smith JC; Sapkota GP
EMBO Rep; 2018 Apr; 19(4):. PubMed ID: 29514862
[TBL] [Abstract][Full Text] [Related]
22. Casein kinase 1 α phosphorylates the Wnt regulator Jade-1 and modulates its activity.
Borgal L; Rinschen MM; Dafinger C; Hoff S; Reinert MJ; Lamkemeyer T; Lienkamp SS; Benzing T; Schermer B
J Biol Chem; 2014 Sep; 289(38):26344-26356. PubMed ID: 25100726
[TBL] [Abstract][Full Text] [Related]
23. Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex.
Luo W; Peterson A; Garcia BA; Coombs G; Kofahl B; Heinrich R; Shabanowitz J; Hunt DF; Yost HJ; Virshup DM
EMBO J; 2007 Mar; 26(6):1511-21. PubMed ID: 17318175
[TBL] [Abstract][Full Text] [Related]
24. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.
Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S
Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
Zheng L; Liu Y; Pan J
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
[TBL] [Abstract][Full Text] [Related]
26. Wnt pathway mutations selected by optimal beta-catenin signaling for tumorigenesis.
Cho KH; Baek S; Sung MH
FEBS Lett; 2006 Jun; 580(15):3665-70. PubMed ID: 16764864
[TBL] [Abstract][Full Text] [Related]
27. Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway.
Hendriksen J; Jansen M; Brown CM; van der Velde H; van Ham M; Galjart N; Offerhaus GJ; Fagotto F; Fornerod M
J Cell Sci; 2008 Jun; 121(11):1793-802. PubMed ID: 18460581
[TBL] [Abstract][Full Text] [Related]
28. Pyrvinium, a potent small molecule Wnt inhibitor, increases engraftment and inhibits lineage commitment of mesenchymal stem cells (MSCs).
Saraswati S; Deskins DL; Holt GE; Young PP
Wound Repair Regen; 2012; 20(2):185-93. PubMed ID: 22332749
[TBL] [Abstract][Full Text] [Related]
29. Fas-associated factor 1 antagonizes Wnt signaling by promoting β-catenin degradation.
Zhang L; Zhou F; van Laar T; Zhang J; van Dam H; Ten Dijke P
Mol Biol Cell; 2011 May; 22(9):1617-24. PubMed ID: 21411632
[TBL] [Abstract][Full Text] [Related]
30. Basic region of residues 228-231 of protein kinase CK1alpha is involved in its interaction with axin: binding to axin does not affect the kinase activity.
Sobrado P; Jedlicki A; Bustos VH; Allende CC; Allende JE
J Cell Biochem; 2005 Feb; 94(2):217-24. PubMed ID: 15565646
[TBL] [Abstract][Full Text] [Related]
31. Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
Li B; Fei DL; Flaveny CA; Dahmane N; Baubet V; Wang Z; Bai F; Pei XH; Rodriguez-Blanco J; Hang B; Orton D; Han L; Wang B; Capobianco AJ; Lee E; Robbins DJ
Cancer Res; 2014 Sep; 74(17):4811-21. PubMed ID: 24994715
[TBL] [Abstract][Full Text] [Related]
32. Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation.
Venerando A; Girardi C; Ruzzene M; Pinna LA
Biochem J; 2013 May; 452(1):131-7. PubMed ID: 23438105
[TBL] [Abstract][Full Text] [Related]
33. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
34. MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling.
Huang Q; Chen L; Schonbrunn E; Chen J
EMBO J; 2020 Jul; 39(14):e104410. PubMed ID: 32511789
[TBL] [Abstract][Full Text] [Related]
35. Casein kinase 1 and Wnt/β-catenin signaling.
Cruciat CM
Curr Opin Cell Biol; 2014 Dec; 31():46-55. PubMed ID: 25200911
[TBL] [Abstract][Full Text] [Related]
36. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin.
Jiang Y; Prunier C; Howe PH
Oncogene; 2008 Mar; 27(13):1865-75. PubMed ID: 17922036
[TBL] [Abstract][Full Text] [Related]
38. [Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].
Liu Y; Zhang CG; Zhou CY
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):238-42. PubMed ID: 20396373
[TBL] [Abstract][Full Text] [Related]
39. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
[TBL] [Abstract][Full Text] [Related]
40. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
